SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

The sharp rally has no confirmed company-news catalyst; traders are focused on anticipation of the REGAL Phase 3 final analysis, which is triggered at 80 survival events after the last disclosed count of 78. Some interpret the CEOs anniversary message and SELLASs planned ASH presence as signs of a potential buyout, while others call that speculation and see the move as a rebound or possible short covering.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs quarterly earnings report is the dominant focus, with traders watching guidance, subscriber engagement and advertising growth amid concerns about competition and a prolonged share-price decline. Many expect further weakness, while bulls argue pessimism is already priced in and see room for a rebound if results or the outlook are stronger than feared.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is drawing attention as traders position around the full Phase 3 melanoma results for its personalized cancer vaccine, intismeran, with Merck; the prior positive topline result has fueled a sharp rally. Bulls see validation of a broader oncology platform, while skeptics warn that expectations and valuation are stretched and debate a possible sell-the-news reaction.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

SRPTs sharp rebound is being attributed by traders to possible short covering and anticipation of upcoming DM1 and FSHD siRNA data, with Arrowheads RNAi results cited as supportive context. No new Sarepta catalyst is confirmed in the discussion, and some traders view the move as technical or part of broader biotech strength.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IRENs steep selloff is being discussed amid broader neocloud concerns about financing, AI infrastructure spending returns, and whether providers can remain independent; traders also point to dilution and possible project delays. The community is split between bearish views that the weakness may persist and bullish arguments that IRENs cash-funded data centers and customer prepayments distinguish it from more debt-heavy peers.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GMs quarterly earnings beat and new share-repurchase authorization are being overshadowed by a narrowed full-year profit outlook whose midpoint was unchanged, prompting a sharp selloff. Traders are split between viewing the buyback and stronger cash-flow outlook as support and seeing cautious guidance, lower U.S. sales, and cost pressures as reasons for the decline.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solanas volatile pullback and bounce amid broader crypto weakness are driving discussion, with traders watching support and Bitcoins direction. Dip-buyers are accumulating and staking, while bearish traders warn the recovery may fail and expect further downside.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA is drawing attention as it approaches and tests its 200-day moving average ahead of earnings, with traders watching for stronger volume and sustained momentum. Optimism about ASCENIV growth and share repurchases is tempered by calls for earnings to validate the outlook and lingering concerns over BIVIGAM weakness and management credibility.

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Myriad Genetics, Inc.

Myriads agreement to sell its prenatal testing business to Labcorp is driving the sharp rally, with traders viewing the cash transaction as a potential balance-sheet and strategic reset. Bulls welcome the deal and momentum, while skeptics argue the sale removes a revenue-generating business and leaves concerns about declining operations and debt; the transaction remains subject to approval.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Intuitive Surgical is drawing attention after a sharp post-earnings selloff despite beating expectations, as investors focused on slower U.S. da Vinci procedure growth and a cautious outlook. Traders are split between viewing the decline as an overreaction given the companys robotic-surgery position and recurring revenue, and seeing valuation, competition, and growth uncertainty as reasons for a reset.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

RKLB Stock’s Slide Hits Day 7: Cathie Wood’s ARK Buys The Dip As Rocket Lab Touts Mars Record Amid Neutron Delay 

Equity

Rocket Lab highlighted its hardware’s role in Perseverance’s record-setting 28.1-mile journey on Mars.

Cathie Wood-Led Ark Invest Sells AMD, SPCX, GOOG Stocks — But Loads Up On CMPS, NTLA, CRSP And Other Healthcare Firms

The trades put some of Ark's better-known holdings on the sell side, including AMD, Alphabet, and SpaceX, while its genomics-focused ARK Genomic Revolution ETF continued to add to biotech companies.

JOBY Stock Drops To Near Two-Year Lows After Barclays Downgrade On Manufacturing Capacity Doubts 

Sector peer Archer Aviation, meanwhile, gained a bullish outlook from Barclays. 

RKLB Rises Overnight: Cathie Wood’s ARK Puts Neutron ‘Close To The Falcon 9’ — Firms ‘In Dire Need’ Of Launches 

SpaceX’s Starlink and upcoming StarMind deployments could create an opening for Rocket Lab if Neutron delivers.

Cathie Wood’s ARK Invest Adds Kratos Defense, AeroVironment Stocks As Pentagon Bets On Drones To Drive Future Warfare

ARK Invest bought millions of dollars worth of Kratos and AeroVironment shares, increasing its drone investments as the Pentagon pushes ahead with autonomous warfare plans. 


Cathie Wood’s ARK Invest Loads Up On Joby, Archer Aviation As Airtaxi, Defense Prospects Grow 

ARK Invest bought 2.56 million Archer shares and 753,000 Joby shares, investing $16.2 million.

Cathie Wood’s ARKG Is Crushing Her Other ETFs: 2 Biotech Bets Have Surged Nearly 6X This Year 

Twist’s Lilly agreement and involvement in Anthropic research highlight its role in building and testing AI-designed proteins.

RKLB Stock’s 2-Week Rally Is On The Line — But Cathie Wood’s ARK Is Loading Up As Wall Street Sees 55% Upside 

ARK Investment Management bought 233,482 RKLB shares across ARKK, ARKQ and ARKX, worth about $16.5 million.

Teradyne Partners With GS Microelectronics On New Semiconductor Test Center — Targets AI, Silicon Photonics And Auto Chips

The multi-year partnership gives chip developers access to Teradyne’s advanced test systems as increasingly complex AI and next-generation semiconductor designs require more intensive evaluation before production.

RKLB Stock Slips After $700M NASA Snub: Cathie Wood Buys The Dip As Retail Blames Neutron Delays

Rocket Lab had proposed an Explorer-based Mars orbiter featuring optical communications and said it felt “strongly positioned” to win.

ARK ETF Trust - ARK Autonomous Technology & Robotics ETF

Bullish Sentiment

<ul class="summary-bullets"><li>Cathie Wood’s ARK bought 168,633 RKLB shares across three ETFs, worth about $9.32 million at Thursday’s close.</li><li>Its acquired businesses supplied solar panels for the journey to Mars and camera mechanisms and robotics for surface exploration.</li><li>Neutron’s debut shifted to 2027 after a manufacturing issue, keeping launch execution in investors’ focus.</li></ul>Shares of Rocket Lab (RKLB) edged 0.2% lower overnight late Thursday even as Cathie Wood’s ARK Investment Management bought the dip and the company highlighted its hardware’s role in NASA’s record-breaking Mars rover mission, with investors still focused on Neutron’s delayed debut.<a href="https://stocktwits.com/symbol/RKLB">RKLB stock</a> tumbled nearly 7% on Thursday to 55.25, logging its seventh straight session of losses. Shares are also nearing one-year lows.&nbsp;<h2 class="st-heading-2">Cathie Wood’s ARK Buys the Dip</h2>ARK’s latest disclosures showed it bought 168,633 Rocket Lab shares Thursday, worth about $9.32 million at the closing price. The ARK Innovation ETF (ARKK) led the purchases with 120,655 shares. The ARK Autonomous Technology &amp; Robotics ETF (ARKQ) added 34,387 shares, while the ARK Space Exploration &amp; Innovation ETF (ARKX) bought 13,591 shares. The combined purchases are worth about $9.32 million based on RKLB’s last closeThe buying follows last month's purchases, when ARK acquired 705,102 Rocket Lab shares over two days across the same three funds, worth about $44.4 million at the time. A separate ARKX purchase added another 2,341 shares, valued at about $154,000.<h2 class="st-heading-2">Rocket Lab Highlights Hardware Behind NASA’s Mars Record</h2>Rocket Lab highlighted its hardware’s role in NASA’s Perseverance mission after the rover broke the record for the farthest distance driven on another world. “28.1 miles on Mars, powered by Rocket Lab hardware,” the company<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/RocketLab/status/2110805629266960529">&nbsp;said on X</a>.Perseverance reached 28.10 miles on Oct.11, surpassing Opportunity’s 28.06-mile record in five and a half years, marking a distance its predecessor took almost 15 years to cover. SolAero solar panels powered the spacecraft carrying Perseverance to Mars. On the surface, Motiv Space Systems’ camera mechanisms help scientists zoom in on targets, while its seven-foot robotic arm places instruments against rocks with precision finer than a millimeter.Rocket Lab acquired SolAero in 2022 and Motiv in May, renaming the latter Rocket Lab Robotics. Both developed their mission hardware before the acquisitions, which broadened Rocket Lab’s business beyond launches.NASA credited AutoNav, the rover’s self-driving system, with much of the progress, as it identifies hazards and plans routes while moving. “Every mile is another step in the search for signs of ancient life,” Rocket Lab said.Meanwhile, Rocket Lab also&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/RocketLab/status/2110880832055546043">welcomed</a> California Governor Gavin Newsom to its Long Beach production complex. Newsom praised the company’s operations, saying California was “engineering, manufacturing, and launching” the future of science and space exploration.<h2 class="st-heading-2">Neutron Delay Keeps Execution in Focus</h2>However, investors' immediate concern is Neutron, the reusable medium-lift rocket intended to expand Rocket Lab’s access to larger launch missions. Rocket Lab said late Wednesday that Neutron’s inaugural flight is now expected in 2027, moving beyond its previous fourth-quarter 2026 target.The development update identified voids, or air pockets, in a newly manufactured carbon-composite forward propellant dome for the rocket’s first stage.The company said engineers replicated the issue, changed the manufacturing process, and validated the changes on an aft dome. The company is manufacturing a replacement forward dome, but it still needs further assembly and testing before it can provide a firmer launch date.<h2 class="st-heading-2">How Do Retail Traders Feel About RKLB?</h2>On Stocktwits, retail sentiment for RKLB slipped to ‘extremely bearish’ from ‘bearish’ levels a day ago amid ‘high’ message volume.<figure class="image"><img src="https://news.stocktwits-cdn.com/rklb_ss_13ef75f03e.png" alt="rklb ss.png" width="655" height="339"><figcaption>RKLB sentiment and message volume as of October 15 | Source: Stocktwits</figcaption></figure>One user&nbsp;<a href="https://stocktwits.com/SideKick21/message/666649621">shared</a> the Perseverance post with the caption, “Powered by $RKLB.” Another&nbsp;<a href="https://stocktwits.com/ASE2SNA/message/666650906">called</a> the milestone “SOO cool” and said they had seen the news without realizing Rocket Lab equipment was involved.On Neutron, one user defended the company,&nbsp;<a href="https://stocktwits.com/TheBullishTrade/message/666629399">saying</a>, “Its a delay. Not cancel.” Others remained skeptical. One user&nbsp;<a href="https://stocktwits.com/MuskyFlex/message/666650704">questioned</a> Rocket Lab’s valuation relative to revenue and profitability, while another argued the stock was “not priced for Neutron delays.”RKLB stock has declined 21% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/mrna-stock-hits-fresh-52-week-highs-as-goldman-raises-target-ahead-of-melanoma-data/cZxh3NsRBrS">MRNA Stock Hits Fresh 52-Week Highs As Goldman Raises Target Ahead Of Melanoma Data&nbsp;</a>

In this photo illustration, the logo of Rocket Lab USA, Inc. is displayed on a smartphone screen.

RKLB Stock’s Slide Hits Day 7: Cathie Wood’s ARK Buys The Dip As Rocket Lab Touts Mars Record Amid Neutron Delay

ARK Innovation ETF

ARK Autonomous Technology & Robotics ETF

ARK Space Exploration & Innovation ETF

Tema Space Innovators ETF

Rocket Lab USA Inc

Defiance Daily Target 2X Long RKLB ETF

Double beat (rev + EPS)

Revenue beat, EPS miss

EPS beat, revenue miss

Double miss

SpaceX ($SPCX) reports earnings after the close today. What do you expect?

Stocktwits

SpaceX

) reports earnings after the close today. What do you expect?

Feed

News

Sentiment

Fundamentals

Info

ARKQ ARK Autonomous Technology & Robotics ETF

Fundamentals

Latest ARKQ News